Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

Andrea Antinori; Antonio Di Biagio; Simone Marcotullio; Massimo Andreoni; Antonio Chirianni; Antonella D.arminio Monforte; Massimo Galli; Francesco Mazzotta; Cristina Mussini; Massimo Puoti; Adriano Lazzarin

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

Andrea Antinori, Antonio Di Biagio, Simone Marcotullio, Massimo Andreoni, Antonio Chirianni, Antonella D.arminio Monforte, Massimo Galli, Francesco Mazzotta, Cristina Mussini, Massimo Puoti, Adriano Lazzarin

Research output: Contribution to journal › Article › peer-review

Abstract

The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.

Original language	English
Pages (from-to)	86-98
Number of pages	13
Journal	New Microbiologica
Volume	40
Issue number	2
Publication status	Published - Apr 1 2017

Keywords

Antiretroviral agents.
Guidelines
HIV
Italy

ASJC Scopus subject areas

Microbiology (medical)

Fingerprint Dive into the research topics of 'Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016'. Together they form a unique fingerprint.

Cite this

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016. / Antinori, Andrea; Di Biagio, Antonio; Marcotullio, Simone; Andreoni, Massimo; Chirianni, Antonio; Monforte, Antonella D.arminio; Galli, Massimo; Mazzotta, Francesco; Mussini, Cristina; Puoti, Massimo; Lazzarin, Adriano.

In: New Microbiologica, Vol. 40, No. 2, 01.04.2017, p. 86-98.

Research output: Contribution to journal › Article › peer-review

Antinori, Andrea ; Di Biagio, Antonio ; Marcotullio, Simone ; Andreoni, Massimo ; Chirianni, Antonio ; Monforte, Antonella D.arminio ; Galli, Massimo ; Mazzotta, Francesco ; Mussini, Cristina ; Puoti, Massimo ; Lazzarin, Adriano. / Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016. In: New Microbiologica. 2017 ; Vol. 40, No. 2. pp. 86-98.

@article{db995aab3a954f4cbe39770258033c95,

title = "Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016",

abstract = "The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.",

keywords = "Antiretroviral agents., Guidelines, HIV, Italy",

author = "Andrea Antinori and {Di Biagio}, Antonio and Simone Marcotullio and Massimo Andreoni and Antonio Chirianni and Monforte, {Antonella D.arminio} and Massimo Galli and Francesco Mazzotta and Cristina Mussini and Massimo Puoti and Adriano Lazzarin",

year = "2017",

month = apr,

day = "1",

language = "English",

volume = "40",

pages = "86--98",

journal = "New Microbiologica",

issn = "1121-7138",

publisher = "Luigi Ponzio e figlio Editori",

number = "2",

}

TY - JOUR

T1 - Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

AU - Antinori, Andrea

AU - Di Biagio, Antonio

AU - Marcotullio, Simone

AU - Andreoni, Massimo

AU - Chirianni, Antonio

AU - Monforte, Antonella D.arminio

AU - Galli, Massimo

AU - Mazzotta, Francesco

AU - Mussini, Cristina

AU - Puoti, Massimo

AU - Lazzarin, Adriano

PY - 2017/4/1

Y1 - 2017/4/1

N2 - The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.

AB - The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.

KW - Antiretroviral agents.

KW - Guidelines

KW - HIV

KW - Italy

UR - http://www.scopus.com/inward/record.url?scp=85020761312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020761312&partnerID=8YFLogxK

M3 - Article

C2 - 28513816

AN - SCOPUS:85020761312

VL - 40

SP - 86

EP - 98

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 2

ER -

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this